• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清血管内皮生长因子是急性高原病的一种潜在生物标志物。

Serum vascular endothelial growth factor is a potential biomarker for acute mountain sickness.

作者信息

Nourkami-Tutdibi Nasenien, Küllmer Jennifer, Dietrich Sven, Monz Dominik, Zemlin Michael, Tutdibi Erol

机构信息

Saarland University Medical Center, Hospital for General Pediatrics and Neonatology, Homburg, Germany.

出版信息

Front Physiol. 2023 Mar 30;14:1083808. doi: 10.3389/fphys.2023.1083808. eCollection 2023.

DOI:10.3389/fphys.2023.1083808
PMID:37064896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10098311/
Abstract

Acute mountain sickness (AMS) is the most common disease caused by hypobaric hypoxia (HH) in high-altitude (HA) associated with high mortality when progressing to high-altitude pulmonary edema (HAPE) and/or high-altitude cerebral edema (HACE). There is evidence for a role of pro- and anti-inflammatory cytokines in development of AMS, but biological pathways and molecular mechanisms underlying AMS remain elusive. We aimed to measure changes in blood cytokine levels and their possible association with the development of AMS. 15 healthy mountaineers were included into this prospective clinical trial. All participants underwent baseline normoxic testing with venous EDTA blood sampling at the Bangor University in United Kingdom (69 m). The participants started from Beni at an altitude of 869 m and trekked same routes in four groups the Dhaulagiri circuit in the Nepali Himalaya. Trekking a 14-day route, the mountaineers reached the final HA of 5,050 m at the Hidden Valley Base Camp (HVBC). Venous EDTA blood sampling was performed after active ascent to HA the following morning after arrival at 5,050 m (HVBC). A panel of 21 cytokines, chemokines and growth factors were assessed using Luminex system (IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p40, IL-1ra, sIL-2Rα, IFN-γ, TNF-α, MCP-1, MIP-1α, MIP-1β, IP-10, G-CSF, GM-CSF, EGF, FGF-2, VEGF, and TGF-β1). There was a significant main effect for the gradual ascent from sea-level (SL) to HA on nearly all cytokines. Serum levels for TNF-α, sIL-2Rα, G-CSF, VEGF, EGF, TGF-β1, IL-8, MCP-1, MIP-1β, and IP-10 were significantly increased at HA compared to SL, whereas levels for IFN-γ and MIP-1α were significantly decreased. Serum VEGF was higher in AMS susceptible AMS resistant subjects ( < 0.027, main effect of AMS) and increased after ascent to HA in both AMS groups ( < 0.011, main effect of HA). Serum VEGF increased more from SL values in the AMS susceptible group than in the AMS resistant group ( < 0.049, interaction effect). Cytokine concentrations are significantly altered in HA. Within short interval after ascent, cytokine concentrations in HH normalize to values at SL. VEGF is significantly increased in mountaineers suffering from AMS, indicating its potential role as a biomarker for AMS.

摘要

急性高原病(AMS)是高原地区低压缺氧(HH)导致的最常见疾病,若进展为高原肺水肿(HAPE)和/或高原脑水肿(HACE),则死亡率很高。有证据表明促炎和抗炎细胞因子在AMS的发生中起作用,但AMS的生物学途径和分子机制仍不清楚。我们旨在测量血液细胞因子水平的变化及其与AMS发生的可能关联。15名健康登山者被纳入这项前瞻性临床试验。所有参与者在英国班戈大学(海拔69米)进行了基线常氧测试,并采集静脉乙二胺四乙酸(EDTA)血样。参与者从海拔869米的贝尼出发,分四组沿相同路线徒步,即尼泊尔喜马拉雅山的道拉吉里环线。经过14天的徒步,登山者到达了隐谷大本营(HVBC),最终海拔为5050米。到达5050米(HVBC)后的第二天早上,在主动上升到高原后采集静脉EDTA血样。使用Luminex系统评估了一组21种细胞因子、趋化因子和生长因子(白细胞介素-1β、白细胞介素-2、白细胞介素-4、白细胞介素-6、白细胞介素-8、白细胞介素-10、白细胞介素-12p40、白细胞介素-1受体拮抗剂、可溶性白细胞介素-2受体α、干扰素-γ、肿瘤坏死因子-α、单核细胞趋化蛋白-1、巨噬细胞炎性蛋白-1α、巨噬细胞炎性蛋白-1β、干扰素诱导蛋白10、粒细胞集落刺激因子、粒细胞-巨噬细胞集落刺激因子、表皮生长因子、成纤维细胞生长因子-2、血管内皮生长因子和转化生长因子-β1)。从海平面(SL)逐渐上升到高原对几乎所有细胞因子都有显著的主要影响。与海平面相比,高原地区肿瘤坏死因子-α、可溶性白细胞介素-2受体α、粒细胞集落刺激因子、血管内皮生长因子、表皮生长因子、转化生长因子-β1、白细胞介素-8、单核细胞趋化蛋白-1、巨噬细胞炎性蛋白-1β和干扰素诱导蛋白10的血清水平显著升高,而干扰素-γ和巨噬细胞炎性蛋白-1α的水平显著降低。在AMS易感和AMS抗性受试者中,血清血管内皮生长因子较高(P<0.027,AMS的主要影响),并且在两个AMS组中上升到高原后均升高(P<0.011,高原的主要影响)。与AMS抗性组相比,AMS易感组中血清血管内皮生长因子从海平面值升高得更多(P<0.049,交互作用)。高原地区细胞因子浓度显著改变。在上升后的短时间内,HH中的细胞因子浓度恢复到海平面时的值。患有AMS的登山者中血管内皮生长因子显著升高,表明其作为AMS生物标志物的潜在作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f566/10098311/badce1cdd3c5/fphys-14-1083808-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f566/10098311/770d8f1e540b/fphys-14-1083808-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f566/10098311/badce1cdd3c5/fphys-14-1083808-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f566/10098311/770d8f1e540b/fphys-14-1083808-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f566/10098311/badce1cdd3c5/fphys-14-1083808-g002.jpg

相似文献

1
Serum vascular endothelial growth factor is a potential biomarker for acute mountain sickness.血清血管内皮生长因子是急性高原病的一种潜在生物标志物。
Front Physiol. 2023 Mar 30;14:1083808. doi: 10.3389/fphys.2023.1083808. eCollection 2023.
2
IL-2, IL-17A and TNF-α hold potential as biomarkers for predicting acute mountain sickness prior to ascent.白细胞介素-2、白细胞介素-17A 和肿瘤坏死因子-α 有望成为登山前预测急性高原病的生物标志物。
Cytokine. 2024 Sep;181:156694. doi: 10.1016/j.cyto.2024.156694. Epub 2024 Jul 18.
3
Expression profile of cytokines and chemokines in a mouse high-altitude cerebral edema model.细胞因子和趋化因子在高原脑水肿小鼠模型中的表达谱。
Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231177189. doi: 10.1177/03946320231177189.
4
Soluble Urokinase-Type Plasminogen Activator Receptor Plasma Concentration May Predict Susceptibility to High Altitude Pulmonary Edema.可溶性尿激酶型纤溶酶原激活物受体血浆浓度可能预测高原肺水肿易感性。
Mediators Inflamm. 2016;2016:1942460. doi: 10.1155/2016/1942460. Epub 2016 Jun 9.
5
Acute Mountain Sickness Following Incremental Trekking to High Altitude: Correlation With Plasma Vascular Endothelial Growth Factor Levels and the Possible Effects of Dexamethasone and Acclimatization Following Re-exposure.渐进式徒步前往高海拔地区后发生的急性高原病:与血浆血管内皮生长因子水平的相关性以及再次暴露后地塞米松和适应性的可能影响
Front Physiol. 2021 Oct 21;12:746044. doi: 10.3389/fphys.2021.746044. eCollection 2021.
6
Endothelial selectins in acute mountain sickness and high-altitude pulmonary edema.急性高原病和高原肺水肿中的内皮细胞选择素
Chest. 1997 Dec;112(6):1572-8. doi: 10.1378/chest.112.6.1572.
7
Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.乙酰唑胺对快速主动上升至4559米后肺动脉压及高原肺水肿预防的影响。
J Appl Physiol (1985). 2022 Jun 1;132(6):1361-1369. doi: 10.1152/japplphysiol.00806.2021. Epub 2022 May 5.
8
Acute mountain sickness, inflammation, and permeability: new insights from a blood biomarker study.急性高原病、炎症和通透性:来自血液生物标志物研究的新见解。
J Appl Physiol (1985). 2011 Aug;111(2):392-9. doi: 10.1152/japplphysiol.00391.2011. Epub 2011 Jun 2.
9
Exploration of Acute Phase Proteins and Inflammatory Cytokines in Early Stage Diagnosis of Acute Mountain Sickness.急性期蛋白和炎性细胞因子在急性高原病早期诊断中的探索
High Alt Med Biol. 2018 Jun;19(2):170-177. doi: 10.1089/ham.2017.0126. Epub 2018 Apr 2.
10
Systemic pro-inflammatory response facilitates the development of cerebral edema during short hypoxia.全身促炎反应会在短期缺氧期间促进脑水肿的发展。
J Neuroinflammation. 2016 Mar 11;13(1):63. doi: 10.1186/s12974-016-0528-4.

引用本文的文献

1
Recent advances in predicting acute mountain sickness: from multidimensional cohort studies to cutting-edge model applications.预测急性高原病的最新进展:从多维队列研究到前沿模型应用
Front Physiol. 2024 Jun 24;15:1397280. doi: 10.3389/fphys.2024.1397280. eCollection 2024.
2
Potential therapeutic effects of traditional Chinese medicine in acute mountain sickness: pathogenesis, mechanisms and future directions.中药对急性高原病的潜在治疗作用:发病机制、作用机制及未来方向
Front Pharmacol. 2024 Jun 4;15:1393209. doi: 10.3389/fphar.2024.1393209. eCollection 2024.
3
subsp. Alleviates Acute Injury in Hypoxic Mice.

本文引用的文献

1
High-altitude illnesses: Old stories and new insights into the pathophysiology, treatment and prevention.高原病:关于病理生理学、治疗与预防的旧有故事与新见解
Sports Med Health Sci. 2021 Apr 16;3(2):59-69. doi: 10.1016/j.smhs.2021.04.001. eCollection 2021 Jun.
2
Proteomic and clinical biomarkers for acute mountain sickness in a longitudinal cohort.纵向队列研究中急性高原病的蛋白质组学和临床生物标志物。
Commun Biol. 2022 Jun 6;5(1):548. doi: 10.1038/s42003-022-03514-6.
3
Adaptive Responses to Hypoxia and/or Hyperoxia in Humans.人体对低氧和/或高氧的适应反应。
亚种。缓解缺氧小鼠的急性损伤。
Nutrients. 2024 May 13;16(10):1465. doi: 10.3390/nu16101465.
Antioxid Redox Signal. 2022 Nov;37(13-15):887-912. doi: 10.1089/ars.2021.0280. Epub 2022 Apr 22.
4
Medical Conditions and High-Altitude Travel.医疗状况与高原旅行
N Engl J Med. 2022 Jan 27;386(4):364-373. doi: 10.1056/NEJMra2104829.
5
Acute Mountain Sickness Following Incremental Trekking to High Altitude: Correlation With Plasma Vascular Endothelial Growth Factor Levels and the Possible Effects of Dexamethasone and Acclimatization Following Re-exposure.渐进式徒步前往高海拔地区后发生的急性高原病:与血浆血管内皮生长因子水平的相关性以及再次暴露后地塞米松和适应性的可能影响
Front Physiol. 2021 Oct 21;12:746044. doi: 10.3389/fphys.2021.746044. eCollection 2021.
6
Genome-Wide DNA Methylation Changes Associated With High-Altitude Acclimatization During an Everest Base Camp Trek.在珠峰大本营徒步旅行期间与高原适应相关的全基因组DNA甲基化变化
Front Physiol. 2021 Jun 28;12:660906. doi: 10.3389/fphys.2021.660906. eCollection 2021.
7
Hypoxia and Inflammation: Insights From High-Altitude Physiology.缺氧与炎症:来自高原生理学的见解
Front Physiol. 2021 May 26;12:676782. doi: 10.3389/fphys.2021.676782. eCollection 2021.
8
Physiological responses during ascent to high altitude and the incidence of acute mountain sickness.在高海拔上升过程中的生理反应和急性高原病的发病率。
Physiol Rep. 2021 Apr;9(7):e14809. doi: 10.14814/phy2.14809.
9
EPAS1 and VEGFA gene variants are related to the symptoms of acute mountain sickness in Chinese Han population: a cross-sectional study.EPAS1 和 VEGFA 基因变异与中国汉族人群急性高原病的症状有关:一项横断面研究。
Mil Med Res. 2020 Jul 27;7(1):35. doi: 10.1186/s40779-020-00264-6.
10
Hypoxic-inflammatory responses under acute hypoxia: In Vitro experiments and prospective observational expedition trial.急性低氧下的缺氧-炎症反应:体外实验和前瞻性观察探险试验。
Int J Mol Sci. 2020 Feb 4;21(3):1034. doi: 10.3390/ijms21031034.